Tirzepatide Weight Loss: Fat Mass and Muscle Findings
Key points Tirzepatide was associated with nearly 16% mean weight loss over 24 weeks in adults with overweight or obesity.
Read MoreKey points Tirzepatide was associated with nearly 16% mean weight loss over 24 weeks in adults with overweight or obesity.
Read MoreKey Points A study assessed 128 GLP-1-related videos from Douyin and Bilibili. Longer videos generally received higher scores for information
Read MoreKey Points Summary Genetic variants in the PAM enzyme may reduce response to GLP-1 receptor agonists Around 10% of individuals
Read More